Delivery Order SPE2DB22D1106-SPE2DB25FFBE9
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,169.25 to AmerisourceBergen Drug Corp for the supply of Sulfamethoxazole-Trimethoprim DS tablets (100-count packaging) on September 8, 2025, with completion expected by September 9, 2025. This firm fixed-price delivery order was competitively awarded without any set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor...
- The Defense Logistics Agency awarded a delivery order valued at $2,353.59 to AmerisourceBergen Drug Corp on September 2, 2025, for the supply of Sulfamethoxazole-Trimethoprim DS tablets in quantities of 100 units. This is a firm fixed price, non-set-aside delivery order with an ultimate completion date of September 3, 2025. The award represents a continuation of AmerisourceBergen's pharmaceutical supply services to the federal government, with performance occurring at the company's corporate...
- The Defense Logistics Agency awarded a delivery order valued at $4,453.16 to AmerisourceBergen Drug Corp for sulfamethoxazole-trimethoprim DS tablets (500 count) on August 14, 2025, with a completion date of August 15, 2025. This firm fixed-price, competitively awarded contract represents a routine pharmaceutical supply delivery to support federal medical procurement needs. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. No set-aside...
- The Defense Logistics Agency awarded a $1,174.63 delivery order to AmerisourceBergen Drug Corp on August 21, 2025, for sulfamethoxazole-trimethoprim DS tablets (500 count). This is a firm fixed-price, competitively awarded contract with an ultimate completion date of August 22, 2025, and represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The pharmaceutical product will be performed at the contractor's Conshohocken,...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp for 100 tablets of Sulfamethoxazole-Trimethoprim DS (a common antibiotic combination) under a firm fixed-price contract valued at $1,514.65. This non-set-aside award, executed on July 28, 2025, represents a child order under AmerisourceBergen's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December...
- The Defense Logistics Agency awarded a delivery order valued at $2,806.05 to AmerisourceBergen Drug Corp for the supply of Sulfamethoxazole-TMP DS tablets (100 count) on September 11, 2025, with completion scheduled for September 12, 2025. This non-competitive, firm fixed-price delivery order represents a continuation of the vendor's existing pharmaceutical supply relationship with the federal government. The place of performance is AmerisourceBergen's corporate office in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order valued at $7,149.18 to AmerisourceBergen Drug Corp on August 6, 2025, for the supply of Sulfamethoxazole-Trimethoprim DS tablets in quantities of 500 units. This competitively awarded, firm fixed-price contract carries an ultimate completion date of August 7, 2025, with performance occurring at the contractor's facility in Conshohocken, Pennsylvania. The contract represents a straightforward pharmaceutical procurement with no set-aside...
- The Defense Logistics Agency awarded a delivery order valued at $3,793.79 to AmerisourceBergen Drug Corp for Sulfamethoxazole-Trimethoprim (TMP) DS tablets in quantities of 500 on August 29, 2025, with completion targeted for September 2, 2025. This competitively awarded, firm fixed-price contract contains no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 27, 2025, for the supply of Sulfamethoxazole-Trimethoprim DS tablets (500-count packages) with a ceiling value of $1,688.06. This firm fixed-price delivery order, which carries an ultimate completion date of August 28, 2025, represents a child contract under AmerisourceBergen's larger indefinite delivery contract with DLA Troop Support Medical. The work will be performed at the contractor's corporate...
- The Defense Logistics Agency awarded a $1,628.73 delivery order to AmerisourceBergen Drug Corp on August 26, 2025, for the supply of Sulfamethoxazole-Trimethoprim DS tablets (100 count). This is a firm fixed price, non-set-aside contract with an ultimate completion date of August 27, 2025, and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a routine pharmaceutical procurement supporting federal medical supply requirements,...
- SPE2DB22D1106Indefinite Delivery Contract
- SPE2DB22D1106-SPE2DB25FFBE9Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $1,307.48 to AmerisourceBergen Drug Corp for the supply of Sulfamethoxazole-Trimethoprim DS tablets (500-count packages). This competitively awarded, non-set-aside contract utilizes firm fixed price pricing and specifies a place of performance in Conshohocken, Pennsylvania, with an ultimate completion date of August 4, 2025. The award represents a routine pharmaceutical procurement supporting federal medical supply needs, consistent with DLA's ongoing healthcare logistics operations. This delivery order operates under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. As a major pharmaceutical distributor headquartered in Pennsylvania, AmerisourceBergen serves as a critical vendor for military and veteran healthcare systems, supplying generic and brand-name medications, vaccines, and medical supplies across multiple therapeutic domains. The parent IDC enables flexible procurement of pharmaceutical commodities to support Defense Health Agency operations and other federal healthcare systems worldwide, with DLA planning to establish subsequent Pharmaceutical Prime Vendor Global Program Generation V contracts involving multiple regional contractors.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.3k | 8/2/25 |